← All organizations
Highest phase reached
Phase 1
First clinical trial
Sep 30, 2019Last known activity
Jul 31, 2024
Timeline
2010s
- Jan 1, 2010
IGM Biosciences, Inc.— Founded
Drugs by trial phase (10 distinct, 10 trials)
Phase 1 (10 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT06331832Lead sponsorN/A—
- NCT06524687OfficialPhase 1Jul 31, 2024
- NCT06524687Lead sponsorPhase 1Jul 31, 2024
- NCT06087406Study directorPhase 1Sep 13, 2023
- NCT06087406Lead sponsorPhase 1Sep 13, 2023
- NCT05908396Lead sponsorPhase 1Aug 31, 2023
- NCT05908396Study directorPhase 1Aug 31, 2023
- NCT06041568Lead sponsorPhase 1Aug 15, 2023
- NCT06041568Study directorPhase 1Aug 15, 2023
- NCT05702424Lead sponsorPhase 1Jan 10, 2023
- NCT05702424Study directorPhase 1Jan 10, 2023
- NCT05184218Lead sponsorPhase 1Jan 20, 2022
- NCT05184218Study directorPhase 1Jan 20, 2022
- NCT05160402Study directorPhase 1Dec 7, 2021
- NCT05160402Lead sponsorPhase 1Dec 7, 2021
Details
- Founded
- Mountain View, CA, US Jan 1, 2010
- Last known activity
- Jul 31, 2024